SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615774-17-005018
Filing Date
2017-09-12
Accepted
2017-09-12 09:38:43
Documents
3
Period of Report
2017-09-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s107465_8-k.htm 8-K 30447
2 EXHIBIT 10.01 s107465_ex10-01.htm EX-10.01 98040
3 EXHIBIT 10.02 s107465_ex10-02.htm EX-10.02 157491
  Complete submission text file 0001615774-17-005018.txt   287399
Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258
Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55331 | Film No.: 171080182
SIC: 2834 Pharmaceutical Preparations